Klaria Pharma Holding AB (publ.) (STO:KLAR)
Sweden
· Delayed Price · Currency is SEK 0.790
-0.010 (-1.25%)
Mar 9, 2026, 5:23 PM CET
STO:KLAR Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 8.99 | 2.25 | 8.45 | 5.87 | - | Upgrade
|
| Other Revenue | - | - | - | - | 6.11 | Upgrade
|
| Revenue | 8.99 | 2.25 | 8.45 | 5.87 | 6.11 | Upgrade
|
| Revenue Growth (YoY) | 299.69% | -73.41% | 44.07% | -3.99% | -15.35% | Upgrade
|
| Gross Profit | 8.99 | 2.25 | 8.45 | 5.87 | 6.11 | Upgrade
|
| Selling, General & Admin | 14.16 | 11.43 | 15.91 | 10.16 | 9.86 | Upgrade
|
| Research & Development | 20.06 | 22.11 | 24.95 | 51.36 | 63.49 | Upgrade
|
| Other Operating Expenses | - | - | -0.21 | -0.2 | 13.74 | Upgrade
|
| Operating Expenses | 34.22 | 33.53 | 40.64 | 61.31 | 87.09 | Upgrade
|
| Operating Income | -25.24 | -31.29 | -32.18 | -55.44 | -80.97 | Upgrade
|
| Interest Expense | -13.66 | -16.39 | -3.66 | -7.83 | -3.17 | Upgrade
|
| Interest & Investment Income | - | 0.01 | 0.01 | 0 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | - | -0.04 | 0.02 | -0.38 | 0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.01 | -0.03 | -0.02 | -0.02 | 30.53 | Upgrade
|
| Pretax Income | -38.89 | -47.73 | -35.84 | -63.66 | -53.55 | Upgrade
|
| Income Tax Expense | - | 0.02 | -0.06 | 0.12 | -0.01 | Upgrade
|
| Earnings From Continuing Operations | -38.89 | -47.75 | -35.78 | -63.77 | -53.53 | Upgrade
|
| Net Income | -38.89 | -47.75 | -35.78 | -63.77 | -53.53 | Upgrade
|
| Net Income to Common | -38.89 | -47.75 | -35.78 | -63.77 | -53.53 | Upgrade
|
| Shares Outstanding (Basic) | 189 | 125 | 101 | 58 | 52 | Upgrade
|
| Shares Outstanding (Diluted) | 189 | 127 | 101 | 58 | 52 | Upgrade
|
| Shares Change (YoY) | 49.19% | 25.62% | 73.49% | 12.15% | 19.58% | Upgrade
|
| EPS (Basic) | -0.21 | -0.38 | -0.36 | -1.10 | -1.03 | Upgrade
|
| EPS (Diluted) | -0.21 | -0.38 | -0.36 | -1.10 | -1.03 | Upgrade
|
| Free Cash Flow | -35.04 | -11.91 | -9.06 | -49.77 | -24.8 | Upgrade
|
| Free Cash Flow Per Share | -0.18 | -0.09 | -0.09 | -0.86 | -0.48 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -280.88% | -1391.68% | -380.70% | -944.79% | -1324.82% | Upgrade
|
| Profit Margin | -432.80% | -2124.11% | -423.28% | -1086.81% | -875.88% | Upgrade
|
| Free Cash Flow Margin | -389.95% | -529.67% | -107.14% | -848.18% | -405.71% | Upgrade
|
| EBITDA | -14.02 | -20.07 | -21.15 | -45.09 | -70.61 | Upgrade
|
| EBITDA Margin | -156.01% | - | -250.14% | - | - | Upgrade
|
| D&A For EBITDA | 11.22 | 11.22 | 11.04 | 10.35 | 10.37 | Upgrade
|
| EBIT | -25.24 | -31.29 | -32.18 | -55.44 | -80.97 | Upgrade
|
| EBIT Margin | -280.88% | - | - | - | - | Upgrade
|
| Revenue as Reported | 9 | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.